Downstream abnormalities in fatty acid synthesis and energy generation have been described, though biochemical signs of these perturbations are inconsistent across SLC13A5 deficiency patients. This evidence concerns the gene SLC13A5 and hyperinsulinemic hypoglycemia, familial, 4.